FBXW Antibodies

Santa Cruz Biotechnology features a diverse variety of FBXW Antibodies for investigating F-box proteins in cellular processes. FBXW monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). F-box proteins, particularly those in the FBXW family, are essential components of the ubiquitin-proteasome pathway, regulating protein degradation and maintaining cellular homeostasis. FBXW proteins participate in cell cycle regulation, signal transduction, and stress responses. Research has shown that FBXW proteins significantly impact various diseases, including cancer and neurodegenerative disorders. Understanding FBXW protein function continues to reveal new insights into cellular regulation and disease mechanisms. Advanced research tools enable scientists to explore molecular pathways and cellular processes with greater precision. Current studies focusing on FBXW proteins are uncovering potential therapeutic targets for various diseases. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of cellular processes and disease mechanisms.